These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1689493)

  • 21. In vivo regulation of mu-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice.
    Duttaroy A; Yoburn BC
    Synapse; 2000 Aug; 37(2):118-24. PubMed ID: 10881033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced affinity of mu-opioid receptors in morphine-dependent mice.
    Abdelhamid EE; Takemori AE
    Prog Clin Biol Res; 1990; 328():523-6. PubMed ID: 2154814
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
    Bidlack JM
    NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid receptor upregulation in mu-opioid receptor deficient CXBK and outbred Swiss Webster mice.
    Duttaroy A; Shen J; Shah S; Chen B; Sehba F; Carroll J; Yoburn BC
    Life Sci; 1999; 65(2):113-23. PubMed ID: 10416817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of [3H]DAGO binding by substance P (SP) and SP fragments in the mouse brain and spinal cord via MU1 interactions.
    Krumins SA; Kim DC; Seybold VS; Larson AA
    Neuropeptides; 1989; 13(4):225-33. PubMed ID: 2473408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of Mu receptors in the opioid-induced increase in the turnover of mouse brain histamine.
    Itoh Y; Oishi R; Nishibori M; Saeki K
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1021-6. PubMed ID: 2855235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the antinociceptive and antitransit effects of DAGO and PLO17 in mice.
    Shook JE; Burks TF
    Proc West Pharmacol Soc; 1985; 28():115-7. PubMed ID: 2999803
    [No Abstract]   [Full Text] [Related]  

  • 32. Ontogenesis of cell surface mu-opioid ([3H]DAGO) binding sites in rat hypothalamus and ex vivo determination of blood-brain barrier penetration by opioid peptide FK 33-824.
    Landymore KM; Wilkinson M
    Brain Res Dev Brain Res; 1990 Jul; 54(2):169-76. PubMed ID: 2168820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo determination of opiate antagonist binding at mu-opioid ([3H]-DAGO) receptors in hypothalamic micropunches from maturing female rats: comparison between SDZ 210-096 and nalmefene.
    Landymore KM; Giles A; Wilkinson M
    Neuropeptides; 1992 Mar; 21(3):175-82. PubMed ID: 1321363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DAMGO binding to mouse brain membranes: influence of salts, guanine nucleotides, substance P, and substance P fragments.
    Krumins SA; Kim DC; Igwe OJ; Larson AA
    Peptides; 1993; 14(2):309-14. PubMed ID: 7683401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regionally selective increases in mu opioid receptor density in the brains of suicide victims.
    Gross-Isseroff R; Dillon KA; Israeli M; Biegon A
    Brain Res; 1990 Oct; 530(2):312-6. PubMed ID: 2176118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid mu-deficient CXBK mouse and the role of mu 1-receptors in electrically induced convulsions.
    Yokoyama H; Onodera K; Suzuki T; Iinuma K; Watanabe T
    Brain Res; 1992 Nov; 595(1):137-40. PubMed ID: 1334767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal stress has long-term effects on brain opiate receptors.
    Insel TR; Kinsley CH; Mann PE; Bridges RS
    Brain Res; 1990 Mar; 511(1):93-7. PubMed ID: 2158857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interaction of tetrahydroisoquinolines and 3-aminotetralines with opioid mu-receptors].
    Iarygin KN; Ankudinova ON; Kotin AM
    Bioorg Khim; 1991 Sep; 17(9):1172-6. PubMed ID: 1687237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrachlorodibenzo-p-dioxin alters rat hypothalamic endorphin and mu opioid receptors.
    Bestervelt LL; Nolan CJ; Cai Y; Maimansomsuk P; Mousigian CA; Piper WN
    Neurotoxicol Teratol; 1991; 13(5):495-7. PubMed ID: 1661835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in mu opiate receptors following inescapable shock.
    Stuckey J; Marra S; Minor T; Insel TR
    Brain Res; 1989 Jan; 476(1):167-9. PubMed ID: 2536575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.